Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

Phase I study of AVB-S6-500 demonstrates proof of mechanism

May 11, 2018

FDA identifies deficiencies during NDA review of Methylene Blue MMX

May 11, 2018

Lilly to acquire ARMO BioSciences

May 11, 2018

Phosphodiesterase PDE4 inhibitors patented byTakeda

May 11, 2018

MFN2 agonist restores mitochondrial trafficking in models of Charcot-Marie-Tooth disease type 2A

May 11, 2018

Pharmasum Therapeutics identifies novel DYRK inhibitors

May 11, 2018

Novel PTP-2C inhibitors discovered at DE Shaw Research, Relay Therapeutics

May 11, 2018

Patient recruitment ongoing in phase I trial of PF-06821497

May 11, 2018

Prelude Therapeutics discovers PRMT5 inhibitors

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...